LTF and rhabdomyolysis: This study was the first to demonstrate that METs play a role in the pathogenesis of a disease, suggesting that the use of exogenous lactoferrin to inhibit the formation of MAC1 and METs is a potential therapeutic strategy for the prevention of rhabdomyolysis-induced acute kidney injury [8].